40 Participants NeededMy employer runs this trial

Plan B for Cardiovascular Health

(LEVOH Trial)

JC
Overseen ByJenna C Stone, BSc

What You Need to Know Before You Apply

What is the purpose of this trial?

The goal of this double-blind randomized controlled trial is to learn about the impacts of a single dose of Plan B® on the cardiovascular system in young, health, premenopausal females. The main questions it aims to answer are:

1. What is the short-term affect of Plan B® affect on the venous system?

2. What is the short-term affect of Plan B® affect on the health of arteries?

Researchers will compare a single dose of Plan B® (1.5 mg of levonorgestrel) to a placebo to see if Plan B® has unique effects on the cardiovascular system.

Participants will:

1. Undergo baseline measurements of venous thrombosis markers, blood pressure, and measures of arterial function using ultrasound.

2. Be randomized to either take a Plan B® or placebo pill

3. Repeat baseline measurements of venous thrombosis markers, blood pressure, and measures of arterial function using ultrasound each hour, for 6-hours, and then 24- and 48- hours after taking the Plan B® or placebo pill.

Who Is on the Research Team?

MC

Mark Crowther, MD, MSc, LLM, FRCPC, FRSC

Principal Investigator

McMaster University

MJ

Maureen J MacDonald, PhD

Principal Investigator

McMaster University

Are You a Good Fit for This Trial?

This trial is for healthy, premenopausal women who have not gone through menopause. Participants should not have a history of blood clots or other major health issues that could affect the study results.

Inclusion Criteria

Eumenorrheic (experiencing a predictable menstrual cycle lasting 21-45 days)
In the surrounding Hamilton area or able to visit McMaster for study visits
Not pregnant
See 4 more

Exclusion Criteria

I am currently taking medications that may affect how the study drug works.
Known or suspected pregnancy
I currently have or have had migraines.
See 5 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1 week

Baseline Assessment

Participants undergo baseline measurements of venous thrombosis markers, blood pressure, and measures of arterial function using ultrasound

1 day
1 visit (in-person)

Treatment

Participants are randomized to take a single dose of Plan B® or placebo, followed by repeated measurements of cardiovascular markers

48 hours
Multiple visits (in-person) over 48 hours

Follow-up

Participants are monitored for safety and effectiveness after treatment

1 week

What Are the Treatments Tested in This Trial?

Interventions

  • Levonorgestrel

Trial Overview

The study compares the effects of a single dose of Plan B® (levonorgestrel) to a placebo pill on heart and blood vessel health. It uses random assignment and neither participants nor researchers know which pill is given.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Placebo Group

Group I: Plan B®Experimental Treatment1 Intervention
Group II: PlaceboPlacebo Group1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

McMaster University

Lead Sponsor

Trials
936
Recruited
2,630,000+